Harvard Bioscience Stock Market Value
| HBIO Stock | USD 2.20 0.01 0.46% |
| Symbol | Harvard |
Harvard Bioscience Price To Book Ratio
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Harvard Bioscience. If investors know Harvard will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Harvard Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.80) | Earnings Share (0.33) | Revenue Per Share 2.258 | Quarterly Revenue Growth (0.13) | Return On Assets (0.02) |
The market value of Harvard Bioscience is measured differently than its book value, which is the value of Harvard that is recorded on the company's balance sheet. Investors also form their own opinion of Harvard Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Harvard Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Harvard Bioscience's market value can be influenced by many factors that don't directly affect Harvard Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Harvard Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Harvard Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Harvard Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Harvard Bioscience 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Harvard Bioscience's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Harvard Bioscience.
| 06/08/2023 |
| 11/29/2024 |
If you would invest 0.00 in Harvard Bioscience on June 8, 2023 and sell it all today you would earn a total of 0.00 from holding Harvard Bioscience or generate 0.0% return on investment in Harvard Bioscience over 540 days. Harvard Bioscience is related to or competes with InfuSystems Holdings, Pro Dex, LeMaitre Vascular, Utah Medical, Milestone Scientific, Precision Optics,, and Repro Med. Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental... More
Harvard Bioscience Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Harvard Bioscience's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Harvard Bioscience upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.12) | |||
| Maximum Drawdown | 33.24 | |||
| Value At Risk | (5.90) | |||
| Potential Upside | 6.72 |
Harvard Bioscience Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Harvard Bioscience's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Harvard Bioscience's standard deviation. In reality, there are many statistical measures that can use Harvard Bioscience historical prices to predict the future Harvard Bioscience's volatility.| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.75) | |||
| Total Risk Alpha | (1.06) | |||
| Treynor Ratio | (0.13) |
Harvard Bioscience Backtested Returns
Harvard Bioscience holds Efficiency (Sharpe) Ratio of -0.0531, which attests that the entity had a -0.0531% return per unit of risk over the last 3 months. Harvard Bioscience exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Harvard Bioscience's Standard Deviation of 4.38, risk adjusted performance of (0.06), and Market Risk Adjusted Performance of (0.12) to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of 3.07, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Harvard Bioscience will likely underperform. At this point, Harvard Bioscience has a negative expected return of -0.24%. Please make sure to check out Harvard Bioscience's treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Harvard Bioscience performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.55 |
Modest predictability
Harvard Bioscience has modest predictability. Overlapping area represents the amount of predictability between Harvard Bioscience time series from 8th of June 2023 to 4th of March 2024 and 4th of March 2024 to 29th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Harvard Bioscience price movement. The serial correlation of 0.55 indicates that about 55.0% of current Harvard Bioscience price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.55 | |
| Spearman Rank Test | 0.19 | |
| Residual Average | 0.0 | |
| Price Variance | 0.43 |
Harvard Bioscience lagged returns against current returns
Autocorrelation, which is Harvard Bioscience stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Harvard Bioscience's stock expected returns. We can calculate the autocorrelation of Harvard Bioscience returns to help us make a trade decision. For example, suppose you find that Harvard Bioscience has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Harvard Bioscience regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Harvard Bioscience stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Harvard Bioscience stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Harvard Bioscience stock over time.
Current vs Lagged Prices |
| Timeline |
Harvard Bioscience Lagged Returns
When evaluating Harvard Bioscience's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Harvard Bioscience stock have on its future price. Harvard Bioscience autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Harvard Bioscience autocorrelation shows the relationship between Harvard Bioscience stock current value and its past values and can show if there is a momentum factor associated with investing in Harvard Bioscience.
Regressed Prices |
| Timeline |
When determining whether Harvard Bioscience offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Harvard Bioscience's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Harvard Bioscience Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Harvard Bioscience Stock:
Check out Harvard Bioscience Correlation, Harvard Bioscience Volatility and Harvard Bioscience Alpha and Beta module to complement your research on Harvard Bioscience. To learn how to invest in Harvard Stock, please use our How to Invest in Harvard Bioscience guide.You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Harvard Bioscience technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.